Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS6071280 A
Publication typeGrant
Application numberUS 08/802,195
Publication dateJun 6, 2000
Filing dateFeb 14, 1997
Priority dateNov 8, 1993
Fee statusPaid
Publication number08802195, 802195, US 6071280 A, US 6071280A, US-A-6071280, US6071280 A, US6071280A
InventorsStuart D. Edwards, Ronald G. Lax, Hugh Sharkey
Original AssigneeRita Medical Systems, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Multiple electrode ablation apparatus
US 6071280 A
Abstract
A tissue ablation apparatus includes a delivery catheter with distal and proximal ends. A handle is attached to the proximal end of the delivery catheter. At least partially positioned in the delivery catheter is an electrode deployment device. The electrode deployment devices includes a plurality of retractable electrodes. Each electrode has a non-deployed state when it is positioned in the delivery catheter. Additionally, each electrode has a distended deployed state when it is advanced out of the delivery catheter distal end. The deployed electrodes define an ablation volume. Each deployed electrode has a first section with a first radius of curvature. The first section is located near the distal end of the delivery catheter. A second section of the deployed electrode extends beyond the first section, ad has a second radius of curvature, or a substantially linear geometry.
Images(21)
Previous page
Next page
Claims(46)
What is claimed is:
1. A tissue ablation apparatus, comprising:
an introducer having a distal portion and a proximal portion;
an electrode device positionable within an interior of the introducer as the introducer is advanced through tissue, the electrode device including at least a first RF electrode, a second RF electrode and a third RF electrode, each of the first, second and third RF electrodes having a tissue piercing distal end, a non-deployed state when positioned within the introducer and a deployed state when advanced from the distal portion of the introducer, the first, second and third RF electrodes being deployable with curvature from the introducer distal portion and including a section that is perpendicular to a longitudinal axis of the introducer, the first, second and third RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer;
an electrode advancement and retraction member coupled to the electrode device to advance the first, second and third RF electrodes in and out of the introducer distal portion.
2. The apparatus of claim 1, wherein the RF electrodes are retractable in and out of the distal portion of the introducer.
3. The apparatus of claim 1, wherein the ablation volume is defined substantially by the peripheries of the RF electrodes in the deployed state.
4. The apparatus of claim 1, wherein the ablation volume is defined between the RF electrodes in their deployed states.
5. The apparatus of claim 1, wherein the RF electrodes in their deployed state define a three-dimensional ablation volume.
6. The apparatus of claim 1, wherein the RF electrodes are pre-sprung while retained in the introducer such that on being advanced from the distal portion of the introducer the RF electrodes become deployed and fan out from the distal portion of the introducer.
7. The apparatus of claim 1, wherein the RF electrodes are pre-sprung while retained in the introducer such that on being advanced from the distal portion of the introducer the RF electrodes become deployed and fan out from the distal portion of the introducer through tissue in accordance with the curvature.
8. The apparatus of claim 1, wherein each of the RF electrodes changes direction along a length of the electrode in the deployed state.
9. The apparatus of claim 1, wherein at least one of the RF electrodes exhibits, in the deployed state, at least one curved section located near the distal portion of the introducer and a non-curved section beyond the curved section.
10. The apparatus of claim 1, wherein at least one of the RF electrodes exhibits, in the deployed state, a first section which has a first radius of curvature and a second section which extends beyond the first section and has a second radius of curvature.
11. The apparatus of claim 1, wherein at least one of the RF electrodes exhibits, in the deployed state, at least two radii of curvature.
12. The apparatus of claim 1, wherein at least one of the RF electrodes exhibits, in the deployed state, at least two radii of curvature in one plane.
13. The apparatus of claim 1, wherein at least one of the RF electrodes exhibits, in the deployed state, at least two radii of curvature in at least two planes.
14. The apparatus of claim 1, wherein each RF electrode is made of a memory metal or a sprung steel.
15. The apparatus of claim 1. wherein each RF electrode is hollow and includes a fluid distribution port.
16. The apparatus of claim 15, further comprising a source of infusing medium coupled to each of the RF electrodes.
17. The apparatus of claim 15, further comprising a source of chemotherapeutic agent coupled to each of the RF electrodes.
18. The apparatus of claim 1, further comprising an electrode insulator positioned adjacent to and in surrounding relationship to each of the RF electrodes to define an electrode energy delivery surface.
19. The apparatus of claim 1, wherein the electrode advancement and retraction member is removable from the introducer.
20. The apparatus of claim 1, further comprising:
a handle member coupled to the introducer.
21. The apparatus of claim 1, wherein each RF electrode is wire-like.
22. The apparatus of claim 1, wherein each RF electrode includes a hollow lumen.
23. The apparatus of claim 1, further comprising:
an energy source coupled to the RF electrodes.
24. The apparatus of claim 23, wherein the energy source is an RF source coupled to the RF electrodes.
25. The apparatus of claim 23 further comprising:
a thermal sensor coupled to electrode device.
26. The apparatus of claim 1, wherein the first second and third RF electrodes are bipolar RF electrodes.
27. The apparatus of claim 1, wherein the first second and third RF electrodes are monopolar electrodes.
28. A method of deploying electrodes for defining an ablation volume, the method comprising:
providing an ablation apparatus including at least a first RF electrode, a second RF electrode and an introducer with a proximal portion and a distal portion, each of the RF electrodes having a tissue piercing distal end and configured to be advanceable from the introducer distal with curvature from a non-deployed state when positioned within the introducer to a deployed state when advanced from the introducer distal portion, each of the RF electrodes including a section that is perpendicular to a longitudinal axis of the introducer in the deployed state, the first and second RF electrodes exhibiting a changing direction of travel along a length of electrode deployed from the introducer;
positioning the introducer in a solid tissue mass to a selected tissue site; and
advancing the first and second RF electrodes from the distal portion of the introducer to the deployed state.
29. The method of claim 28 further comprising:
retracting the RF electrodes in and out of the distal portion of the introducer.
30. The method of claim 28 further comprising:
inserting the RF electrodes into tissue so as to penetrate the tissue.
31. The method of claim 28, wherein the ablation volume is substantially defined by the peripheries of the RF electrodes in the deployed state.
32. The method of claim 28, wherein the ablation volume is defined between the deployed RF electrodes.
33. A method of claim 28 further comprising:
deploying the RF electrodes to define a three-dimensional ablation volume.
34. The method of claim 28 further comprising:
advancing the RF electrodes from the distal portion of the introducer such that the RF electrodes become deployed and fan out from the distal portion.
35. The method of claim 28, wherein the RF electrodes are pre-sprung while retained in the introducer such that on being advanced from the distal portion of the introducer the RF electrodes become deployed and fan out from the distal portion of the introducer through tissue in accordance with the radius of curvature.
36. A method of claim 28, wherein at least one of the RF electrodes changes direction along its length in the deployed state.
37. A tissue ablation apparatus, comprising:
an introducer having a distal portion, a distal end at a distal most position of the distal portion, an introducer aperture formed at the distal end and a proximal portion;
an electrode device positionable within an interior of the introducer as the introducer is advanced through tissue, the electrode device including at least a first RF electrode, a second RF electrode and a third RF electrode, each of the first, second and third RF electrodes having a tissue piercing distal end, a non-deployed state when positioned within the introducer and a deployed state when advanced from the distal end of the introducer, the first, second and third RF electrodes being deployable with cuvature from the introducer distal end and including a section that is perpendicular to a longitudinal axis of the introducer, the first, second and third RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer; and
an electrode advancement and retraction member coupled to the electrode device, the electrode advancement and retraction member advancing and retracting the RF electrodes in and out of the introducer distal end.
38. A tissue ablation apparatus, comprising:
an introducer having a distal portion, a distal end and a proximal portion;
an electrode device positionable within an interior of the introducer as the introducer is advanced through tissue, the electrode device including at least a first RF electrode, a second RF electrode and a third RF electrode, each of the first, second and third RF electrodes having a non-deployed state when positioned within the introducer and a deployed state when advanced from the distal end of the introducer, the first, second and third RF electrodes being deployable with curvature from the introducer distal end to define an ablation volume, the first, second and third RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer; and
an electrode advancement and retraction member coupled to the electrode device, the electrode advancement and retraction member advancing and retracting the RF electrodes in and out of the introducer distal end.
39. The apparatus of claim 38, further including an impedance measurement apparatus coupled to the electrode device.
40. A tissue ablation apparatus, comprising:
a rigid introducer having a distal portion and a proximal portion;
an electrode device positionable within an interior of the introducer as the introducer is advanced through tissue, the electrode device including at least a first RF electrode with a tissue piercing distal end and a second RF electrode with a tissue piercing distal end, each of the first and second RF electrodes having a non-deployed state when positioned within the introducer and a deployed state when advanced from the distal portion of the introducer, the first and second RF electrodes being deployable with curvature from the introducer distal portion, the first and second RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer; and
an electrode advancement and retraction member coupled to the electrode device, the electrode advancement and retraction member advancing and retracting the RF electrodes in and out of the introducer distal portion.
41. A tissue ablation apparatus, comprising:
an introducer having a distal portion and a proximal portion;
an electrode device positionable within an interior of the introducer as the introducer is advanced through tissue, the electrode device including at least a first RF electrode with a tissue piercing distal end, a second RF electrode with a tissue piercing distal end and an electrode coupling, each of the first and second RF electrodes having a non-deployed state when positioned within the introducer and a deployed state when advanced from the distal portion of the introducer, the first and second RF electrodes being deployable with curvature from the introducer distal portion, the first and second RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer; and
an electrode advancement and retraction member coupled to the electrode device, the electrode advancement and retraction member advancing and retracting the RF electrodes in and out of the introducer distal end, wherein the electrode device is physically coupled to the electrode advancement and retraction member.
42. The apparatus of claim 41, wherein the electrode advancement member is a rigid electrode introducer.
43. The apparatus of claim 42, further comprising:
a handpiece coupled of the rigid electrode introducer.
44. The apparatus of claim 43, wherein the rigid electrode introducer is coupled to the handpiece.
45. A tissue ablation apparatus, comprising:
an introducer having a distal portion and a proximal portion;
an obturator with a tissue piercing distal end, the obturator being positionable in an interior of the introducer as the obturator is advanced through tissue;
an electrode device positionable within the interior of the introducer, the electrode device including at least a first RF electrode, a second RF electrode and a third RF electrode, each of the first, second and third RF electrodes having a tissue piercing distal end, a non-deployed state when positioned within the introducer and a deployed state when advanced from the distal portion of the introducer, the first, second and third RF electrodes being deployable with curvature from the introducer distal portion and including a section that is perpendicular to a longitudinal axis of the introducer, the first, second and third RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer; and
an electrode advancement and retraction member coupled to the electrode device to advance the first, second and third RF electrodes in and out of the introducer distal portion.
46. A tissue ablation apparatus, comprising:
an introducer having a distal portion and a proximal portion;
an obturator with a tissue piercing distal end, the obturator being positionable in an interior of the introducer as the obturator is advanced through tissue;
an electrode device positionable within the interior of the introducer, the electrode device including an electrode housing and at least a first RF electrode, a second RF electrode and a third RF electrode positionable in the electrode housing, each of the first, second and third RF electrodes having a tissue piercing distal end, a non-deployed state when positioned within the electrode housing and a deployed state when advanced from the distal portion of the introducer, the first, second and third RF electrodes being deployable with curvature from the introducer distal portion and including a section that is perpendicular to a longitudinal axis of the introducer, the first, second and third RF electrodes exhibiting a changing direction of travel along a length of each electrode deployed from the introducer; and
an electrode advancement and retraction member coupled to the electrode device to advance the first, second and third RF electrodes in and out of the introducer distal portion.
Description
CONTINUING APPLICATION DATA

This application is a continuation-in-part of U.S. Ser. No. 08/515,379, filed Aug. 15, 1995, now U.S. Pat. No. 5,683,384, entitled MULTIPLE ELECTRODE ABLATION APPARATUS, which is a continuation-in-part of U.S. Ser. No. 08/290,031 Aug. 12, 1994 now U.S. Pat. No. 5,536,267, issued Jul. 7, 1996 entitled MULTIPLE ELECTRODE ABLATION APPARATUS, which is a continuation-in-part of U.S. Ser. No. 08/148,439 Nov. 8, 1993 now U.S. Pat. No. 5,458,597, issued Oct. 17, 1995, entitled DEVICE FOR TREATING CANCER AND NON-MALIGNANT TUMORS AND METHODS.

BACKGROUND OF THE INVENTION

1. Field of the Invention

This invention relates generally to an apparatus for the treatment and ablation of body masses, such as tumors, and more particularly, to a retractable multiple needle electrode apparatus that surrounds an exterior of a tumor with a plurality of needle electrodes and defines an ablative volume.

2. Description of Related Art

Current open procedures for treatment of tumors are extremely disruptive and cause a great deal of damage to healthy tissue. During the surgical procedure, the physician must exercise care in not cutting the tumor in a manor that creates seeding of the tumor, resulting in metastasis. In recent years development of products has been directed with an emphasis on minimizing the traumatic nature of traditional surgical procedures.

There has been a relatively significant amount of activity in the area of hyperthermia as a tool for treatment of tumors. It is known that elevating the temperature of tumors is helpful in the treatment and management of cancerous tissues. The mechanisms of selective cancer cell eradication by hyperthermia are not completely understood. However, four cellular effects of hyperthermia on cancerous tissue have been proposed, (i) changes in cell or nuclear membrane permeability or fluidity, (ii) cytoplasmic lysomal disintegration, causing release of digestive enzymes, (iii) protein thermal damage affecting cell respiration and the synthesis of DNA or RNA and (iv) potential excitation of immunologic systems. Treatment methods for applying heat to tumors include the use of direct contact radio-frequency (RF) applicators, microwave radiation, inductively coupled RF fields, ultrasound, and a variety of simple thermal conduction techniques.

Among the problems associated with all of these procedures is the requirement that highly localized heat be produced at depths of several centimeters beneath the surface of the body. Certain techniques have been developed with microwave radiation and ultrasound to focus energy at various desired depths. RF applications may be used at depth during surgery. However, the extent of localization is generally poor, with the result that healthy tissue may be harmed. Induction heating gives rise to poor localization of the incident energy as well. Although induction heating may be achieved by placing an antenna on the surface of the body, superficial eddy currents are generated in the immediate vicinity of the antenna. When it is driven using RF current unwanted surface heating occurs diminishing heating to the underlying tissue.

Thus, non-invasive procedures for providing heat to internal tumors have had difficulties in achieving substantial specific and selective treatment.

Hyperthermia, which can be produced from an RF or microwave source, applies heat to tissue but does not exceed 45 degrees C. so that normal cells survive. In thermotherapy, heat energy of greater than 45 degrees C. is applied, resulting in histological damage, desiccation and the denaturization of proteins. Hyperthermia has been applied more recently for therapy of malignant tumors. In hyperthermia, it is desirable to induce a state of hyperthermia that is localized by interstitial current heating to a specific area while concurrently insuring minimum thermal damage to healthy surrounding tissue. Often, the tumor is located subcutaneously and addressing the tumor requires either surgery, endoscopic procedures or external radiation. It is difficult to externally induce hyperthermia in deep body tissue because current density is diluted due to its absorption by healthy tissue. Additionally, a portion of the RF energy is reflected at the muscle/fat and bone interfaces which adds to the problem of depositing a known quantity of energy directly on a small tumor.

Attempts to use interstitial local hyperthermia have not proven to be very successful. Results have often produced nonuniform temperatures throughout the tumor. It is believed that tumor mass reduction by hyperthermia is related the thermal dose. Thermal dose is the minimum effective temperature applied throughout the tumor mass for a defined period of time. Because blood flow is the major mechanism of heat loss for tumors being heated, and blood flow varies throughout the tumor, more even heating of tumor tissue is needed to ensure more effective treatment.

The same is true for ablation of the tumor itself through the use of RF energy. Different methods have been utilized for the RF ablation of masses such as tumors. Instead of heating the tumor it is ablated through the application of energy. This process has been difficult to achieve due to a variety of factors including, (i) positioning of the RF ablation electrodes to effectively ablate all of the mass, (ii) introduction of the RF ablation electrodes to the tumor site and (iii) controlled delivery and monitoring of RF energy to achieve successful ablation without damage to non-tumor tissue.

There have been a number of different treatment methods and devices for minimally invasively treating tumors. One such example is an endoscope that produces RF hyperthermia in tumors, as disclosed in U.S. Pat. No. 4,920,978. A microwave endoscope device is described in U.S. Pat. No. 4,409,993. In U.S. Pat. No. 4,920,978, an endoscope for RF hyperthermia is disclosed.

In U.S. Pat. No. 4,763,671, a minimally invasive procedure utilizes two catheters that are inserted interstitially into the tumor. The catheters are placed within the tumor volume and each is connect to a high frequency power source.

In U.S. Pat. No. 4,565,200, an electrode system is described in which a single entrance tract cannula is used to introduce an electrode into a selected body site.

However, as an effective treatment device, electrodes must be properly positioned relative to the tumor. After the electrodes are positioned, it is then desirable to have controlled application and deposition of RF energy to ablate the tumor. This reduces destruction of healthy tissue.

There is a need for a RF tumor treatment apparatus that is useful for minimally invasive procedures. It would be desirable for such a device to surround the exterior of the tumor with treatment electrodes, defining a controlled ablation volume, and subsequently the electrodes deliver a controlled amount of RF energy. Additionally, there is a need for a device with infusion capabilities during a pre-ablation step, and after ablation the surrounding tissue can be preconditioned with electromagnetic ("EM") energy at hyperthermia temperatures less than 45 degrees. This would provide for the synergistic affects of chemotherapy and the instillation of a variety of fluids at the tumor site after local ablation and hyperthermia.

SUMMARY OF THE INVENTION

An object of the invention is to provide an RF tissue ablation apparatus which ablates a desired tissue site, such as a tumor, in a minimally invasive manner.

Another object of the invention is to provide an RF tissue ablation apparatus which includes a selectable plurality of retractable electrodes which are advanced from a delivery catheter to define an ablation volume.

A further object of the invention is to provide an RF tissue ablation apparatus which includes a plurality of electrodes that are retractable to and from a delivery catheter. The electrodes are at least partially positioned in the delivery catheter in a non-deployed state, and become distended in a deployed state when advanced out a distal end of the delivery catheter, defining the ablation volume.

Another object of the invention is to provide an RF tissue ablation apparatus with deployed electrodes having a first section with a first radius of curvature, and a second section, that extends beyond the first section, having a second radius of curvature or a substantially linear geometry.

Yet another object of the invention is to provide an RF tissue ablation apparatus with deployed electrodes with two or more radii of curvature.

Still another object of the invention is to provide an RF tissue ablation apparatus with deployed electrodes having at least one radii of curvature in two or more planes.

A further object of the invention is to provide an RF tissue ablation apparatus with at least one deployed electrode that has one curved section located near a distal end of the delivery catheter, and a non-curved section extending beyond the curved section of the deployed electrode. The ablation apparatus also includes at least one deployed electrode with at least two radii of curvature.

Yet another object of the invention is to provide a tissue ablation apparatus with a plurality of retractable electrodes, each deployed electrode has at least one curved section located near a distal end of a delivery catheter, and a non-curved section which extends beyond the curved section of the deployed electrode.

These and other objects are attained with a tissue ablation apparatus that includes a delivery catheter, with distal and proximal ends. A handle is attached to the proximal end of the delivery catheter. An electrode deployment apparatus is positioned at least partially in the delivery catheter. It includes a plurality of electrodes that are retractable in and out of the catheter's distal end. The electrodes are in a non-deployed state when they are positioned within the delivery catheter. As they are advanced out the distal end of the catheter they become deployed, and define an ablation volume. Each electrode has a first section with a first radius of curvature, and a second section, extending beyond the first section, having a second radius of curvature or a substantially linear geometry.

Alternatively, each deployed electrode has at least two radii of curvature that are formed when the needle is advanced through the delivery catheter's distal end and becomes positioned at a selected tissue site.

In another embodiment, each deployed electrode has at least one radius of curvature in two or more planes. Further, the electrode deployment apparatus can include at least one deployed electrode having at least radii of curvature, and at least one deployed electrode with at least one radius of curvature in two or more planes.

In a further embodiment, the electrode deployment apparatus has at least one deployed electrode with at least one curved section that is located near the distal end of the delivery catheter, and a non-curved section which extends beyond the curved section of the deployed electrode. The electrode deployment apparatus also has at least one deployed electrode with at least two radii of curvature.

In another embodiment of the invention, each deployed electrode has at least one curved section located near the distal end of the delivery catheter, and a non-curved section that extends beyond the curved section of the deployed electrode.

An electrode template can be positioned at the distal end of the delivery catheter. It assists in guiding the deployment of the electrodes to a surrounding relationship at an exterior of a selected mass in a tissue. The electrodes can be hollow. An adjustable electrode insulator can be positioned in an adjacent, surrounding relationship to all or some of the electrodes. The electrode insulator is adjustable, and capable of being advanced and retracted along the electrodes in order to define an electrode conductive surface.

The electrode deployment apparatus can include a cam which advances and retracts the electrodes in and out of the delivery catheter's distal end. Optionally included in the delivery catheter are one or more guide tubes associated with one or more electrodes. The guide tubes are positioned at the delivery catheter's distal end.

Sources of infusing mediums, including but not limited to electrolytic and chemotherapeutic solutions, can be associated with the hollow electrodes. Electrodes can have sharpened, tapered ends in order to assist their introduction through tissue, and advancement to the selected tissue site.

The electrode deployment apparatus is removable from the delivery catheter. An obturator is initially positioned within the delivery catheter. It can have a sharpened distal end. The delivery catheter can be advanced percutaneously to an internal body organ, or site, with the obturator positioned in the delivery catheter. Once positioned, the obturator is removed, and the electrode deployment apparatus is inserted into the delivery catheter. The electrodes are in non-deployed states, and preferably compacted or spring-loaded, while positioned within the delivery catheter. They are made of a material with sufficient strength so that as the electrodes emerge from the delivery catheter's distal end they are deployed three dimensionally, in a lateral direction away from the periphery of the delivery catheter's distal end. The electrodes continue their lateral movement until the force applied by the tissue causes the needles to change their direction of travel.

Each electrode now has either, (i) a first section with a first radius of curvature, and a second section, extending beyond the first section, having a second radius of curvature or a substantially linear section, (ii) two radii of curvature, (iii) one radius of curvature in two or more planes, or (iv) a combination of two radii of curvature with one of them in two or more planes. Additionally, the electrode deployment apparatus can include one or more of these deployed geometries for the different electrodes in the plurality. It is not necessary that every electrode have the same deployed geometry.

After the electrodes are positioned around a mass, such as a tumor, a variety of solutions, including but not limited to electrolytic fluids, can be introduced through the electrodes to the mass in a pre-ablation step. RF energy is applied, and the mass is desiccated. In a post-ablation procedure, a chemotherapeutic agent can then be introduced to the site, and the electrodes are then retracted back into the introducing catheter. The entire ablative apparatus can be removed, or additional ablative treatments be conducted.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a perspective view of the tissue ablation apparatus of the invention, including a delivery catheter, handle, and deployed electrodes.

FIG. 2 is a cross-sectional view of the tissue ablation apparatus of the invention illustrated in FIG. 1.

FIG. 3 is a perspective view of an electrode of the invention with two radii of curvature.

FIG. 4 is a perspective view of an electrode of the invention with one radius of curvature in three planes.

FIG. 5 is a perspective view of an electrode of the invention with one curved section, positioned close to the distal end of the delivery catheter, and a linear section.

FIG. 6 is a perspective view of an electrode of the invention with one curved section, positioned close to the distal end of the delivery catheter, a generally first linear section, and then a second linear section that continues laterally with regard to the first linear section.

FIG. 7 is a cross-section view of a delivery catheter associated with the invention, with guide tubes positioned at the distal end of the delivery catheter.

FIG. 8 is a cross-sectional view of an electrode of the invention.

FIG. 9 is a perspective view of the tissue ablation apparatus of the invention shown in FIG. 1, with the delivery catheter being introduced percutaneously through the body and positioned at the exterior, or slightly piercing, a liver with a tumor to be ablated.

FIG. 10 is a perspective view of the tissue ablation apparatus of the invention with an obturator positioned in the delivery catheter.

FIG. 11 is a perspective view of the tissue ablation apparatus of the invention shown in FIG. 10, positioned in the body adjacent to the liver, with the obturator removed.

FIG. 12 is a perspective view of the tissue ablation apparatus of the invention shown in FIG. 10, positioned in the body adjacent to the liver, and the electrode deployment apparatus, with an electrode template, is positioned in the delivery catheter in place of the obturator.

FIG. 13 is a perspective view of the ablation apparatus of the invention, with deployed electrodes surrounding a tumor and defining an ablation volume.

FIG. 14 is a perspective view of the tissue ablation apparatus of the invention shown in FIG. 10, positioned in the body adjacent to the liver, with deployed electrodes surrounding a tumor and infusing a solution to the tumor site during a pre-ablation procedure.

FIG. 15 is a perspective view of the tissue ablation apparatus of the invention shown in FIG. 10, illustrating application of RF energy to the tumor.

FIG. 16 is a perspective view of the tissue ablation apparatus of the invention, illustrating the electro-desiccation of the tumor.

FIG. 17 is a perspective view of the tissue ablation apparatus of the invention, illustrating the instillation of solutions to the tumor site during a postablation procedure.

FIG. 18 illustrates bipolar ablation between electrodes of the invention.

FIG. 19 illustrates monopolar ablation between electrodes of the invention.

FIG. 20 is a perspective view of an ablation system of the invention, including RF and ultrasound modules, and a monitor.

FIG. 21 is a block diagram of the ablation system of the invention.

DETAILED DESCRIPTION

A tissue ablation apparatus 10 of the invention is illustrated in FIG. 1. Ablation apparatus 10 includes a delivery catheter 12, well known to those skilled in the art, with a proximal end 14 and a distal end 16. Delivery catheter 12 can be of the size of about 5 to 16 F. A handle 18 is removably attached to proximal end 14. An electrode deployment device is at least partially positioned within delivery catheter 12, and includes a plurality of electrodes 20 that are retractable in and out of distal end 16. Electrodes 20 can be of different sizes, shapes and configurations. In one embodiment, they are needle electrodes, with sizes in the range of 27 to 14 gauge. Electrodes 20 are in non-deployed positions while retained in delivery catheter. In the non-deployed positions, electrodes 20 may be in a compacted state, spring loaded, generally confined or substantially straight if made of a suitable memory metal such as nitinol. As electrodes 20 are advanced out of distal end 16 they become distended in a deployed state, which defines an ablative volume, from which tissue is ablated as illustrated more fully in FIG. 2. Electrodes 20 operate either in the bipolar or monopolar modes. When the electrodes are used in the bipolar mode, the ablative volume is substantially defined by the peripheries of the plurality of electrodes 20. In one embodiment, the cross-sectional width of the ablative volume is about 4 cm. However, it will be appreciated that different ablative volumes can be achieved with tissue ablation apparatus 10.

The ablative volume is first determined to define a mass, such as a tumor, to be ablated.

Electrodes 20 are placed in a surrounding relationship to a mass or tumor in a predetermined pattern for volumetric ablation. An imaging system is used to first define the volume of the tumor or selected mass. Suitable imaging systems include but are not limited to, ultrasound, computerized tomography (CT) scanning, X-ray film, X-ray fluoroscopy, magnetic resonance imaging, electromagnetic imaging, and the like. The use of such devices to define a volume of a tissue mass or a tumor is well known to those skilled in the art.

With regard to the use of ultrasound, an ultrasound transducer transmits ultrasound energy into a region of interest in a patient's body. The ultrasound energy is reflected by different organs and different tissue types. Reflected energy is sensed by the transducer, and the resulting electrical signal is processed to provide an image of the region of interest. In this way, the ablation volume is then ascertained, and the appropriate electrode deployment device is inserted into delivery catheter 12.

The ablative volume is substantially defined before ablation apparatus 10 is introduced to an ablative treatment position. This assists in the appropriate positioning of ablation apparatus 10. In this manner, the volume of ablated tissue is reduced and substantially limited to a defined mass or tumor, including a certain area surrounding such a tumor, that is well controlled and defined. A small area around the tumor is ablated in order to ensure that all of the tumor is ablated.

With reference again to FIG. 2, electrode sections 20(a) are in deployed states when they are introduced out of distal end 16. Although electrodes 20 are generally in a non-distended configuration in the non-deployed state while positioned in delivery catheter 12, they can also be distended. Generally, electrode sections 20(b) are in retained positions while they are non-deployed. This is achieved by a variety of methods including but not limited to, (i) the electrodes are pre-sprung, confined in delivery catheter 12, and only become sprung (expanded) as they are released from delivery catheter 12, (ii) the electrodes are made of a memory metal, as explained in further detail below, (iii) the electrodes are made of a selectable electrode material which gives them an expanded shape outside of delivery catheter 12, or (iv) delivery catheter 12 includes guide tubes which serve to confine electrodes 12 within delivery catheter 12 and guide their direction of travel outside of the catheter to form the desired, expanded ablation volume. As shown in FIG. 2, electrodes 20 are pre-sprung while retained in delivery catheter 12. This is the non-deployed position. As they are advanced out of delivery catheter 12 and into tissue, electrodes 20 become deployed and begin to "fan" out from distal end 16, moving in a lateral direction relative to a longitudinal axis of delivery catheter 12. As deployed electrodes 20 continue their advancement, the area of the fan increases and extends beyond the diameter of distal end 16.

Significantly, each electrode 20 is distended in a deployed position, and collectively, the deployed electrodes 20 define a volume of tissue that will be ablated. As previously mentioned, when it is desired to ablate a tumor, either benign or malignant, it is preferable to ablate an area that is slightly in excess to that defined by the exterior surface of the tumor. This improves the chances that all of the tumor is eradicated.

Deployed electrodes 20 can have a variety of different deployed geometries including but not limited to, (i) a first section with a first radius of curvature, and a second section, extending beyond the first section, having a second radius of curvature or a substantially linear geometry, (ii) at least two radii of curvature, (iii) at least one radius of curvature in two or more planes, (iv) a curved section, with an elbow, that is located near distal end 16 of delivery catheter, and a non-curved section that extends beyond the curved section, or (v) a curved section near distal end 16, a first linear section, and then another curved section or a second linear section that is angled with regard to the first linear section. Deployed electrodes 20 need not be parallel with respect to each other. The plurality of deployed electrodes 20, which define a portion of the needle electrode deployment device, can all have the same deployed geometries, i.e., all with at least two radii of curvature, or a variety of geometries, i.e., one with two radii of curvature, a second one with one radius of curvature in two planes, and the rest a curved section near distal end 16 of delivery catheter 12 and a non-curved section beyond the curved section.

A cam 22, or other actuating device, can be positioned within delivery catheter and used to advance and retract electrodes 20 in and out of delivery catheter 12. The actual movement of cam can be controlled at handle 18. Suitable cams are of conventional design, well known to those skilled in the art.

The different geometric configurations of electrodes 20 are illustrated in FIGS. 3 through 6. In FIG. 3, electrode 20 has a first radius of curvature 20(c) and a second radius of curvature 20(d). It can include more than two radii of curvature. As shown in FIG. 4, electrode 20 has at least one radius of curvature which extends to three planes. In FIG. 5, each electrode has a first curved section 20(e) which is near distal end 16 of delivery catheter 12. A first generally linear section 20(f) extends beyond curved section 20(e), and the two meet at an elbow 20(g). The electrodes 20 can serve as anodes and cathodes. The plurality of electrodes 20 can have linear sections 20(f) that are generally parallel to each other, or they can be non-parallel. FIG. 6 illustrates an electrode 20 that includes a first curved section 20(e) positioned near distal end 16 of delivery catheter 12, a first linear section 20(f), and a second linear section 20(h) which extends beyond first linear section 20(f). Section 20(h) can be linear, curved, or a combination of the two. The plurality of electrodes 20 illustrated in FIG. 6 can have parallel or non-parallel first linear sections 20(f).

In one embodiment of the invention, electrodes 20 are spring-loaded, and compacted in their non-deployed positions. As electrodes 20 are advanced out of distal end 16 of delivery catheter 12, they become deployed and fan out. Electrodes 20 continue this fanning out direction until the resistance of the tissue overcomes the strength of the material forming electrode 20. This causes electrode 20 to bend and move in a direction inward relative to its initial outward fanning direction. The bending creates curved sections 20(c) and 20(d) of FIG. 3, and can also result in the formation of the other electrode 20 geometries of FIGS. 4, 5 and 6. The extent of electrode 20 fan like travel is dependent on the strength of the material from which it is made. Suitable electrode materials include stainless steel, platinum, gold, silver, copper and other electromagnetic conducting materials including conductive polymers. Preferably, electrode 20 is made of stainless steel or nickel titanium and has dimensions of about 27 to 14 gauge.

In one embodiment, electrode 20 is made of a memory metal, such as nickel titanium, commercially available from Raychem Corporation, Menlo Park, Calif. Additionally, a resistive heating element can be positioned in an interior lumen of electrode 20. Resistive heating element can be made of a suitable metal that transfers heat to electrode 20, causing deployed electrode 20 to become deflected when the temperature of electrode 20 reaches a level that causes the electrode material, such as a memory metal, to deflect, as is well known in the art. Not all of electrode 20 need be made of a memory metal. It is possible that only that distal end portion of electrode 20, which is introduced into tissue, be made of the memory metal in order to effect the desired deployed geometrical configuration. Additionally, mechanical devices, including but not limited to steering wires, can be attached to the distal end of electrode 20 to cause it to become directed, deflected and move about in a desired direction about the tissue, until it reaches its final resting position to ablate a tissue mass.

Optionally included in the delivery catheter are one or more guide tubes 24, FIG. 7, which serve to direct the expansion of electrodes 20 in the fan pattern as they are advanced out of distal end 16 of the delivery catheter 12. Guide tubes 24 can be made of stainless steel, spring steel and thermal plastics including but not limited to nylon and polyesters, and are of sufficient size and length to accommodate the electrodes to a specific site in the body.

FIG. 8 illustrates one embodiment of electrode 20 with a sharpened distal end 24. By including a tapered, or piercing end 24, the advancement of electrode 20 through tissue is easier. Electrode 20 can be segmented, and include a plurality of fluid distribution ports 26, which can be evenly formed around all or only a portion of electrode 20. Fluid distribution ports 26 are formed in electrode 20 when it is hollow and permit the introduction and flow of a variety of fluidic mediums through electrode 20 to a desired tissue site. Such fluidic mediums include, but are not limited to, electrolytic solutions, pastes or gels, as well as chemotherapeutic agents. Examples of suitable conductive gels are carboxymethyl cellulose gels made from aqueous electrolyte solutions such as physiological saline solutions, and the like.

The size of fluid distribution ports 26 can vary, depending on the size and shape of electrode 20. Also associated with electrode 20 is an adjustable insulator sleeve 28 that is sidable along an exterior surface of electrode 20. Insulator sleeve 28 is advanced and retracted along electrode 20 in order to define the size of a conductive surface of electrode 20. Insulator sleeve 28 is actuated at handle 18 by the physician, and its position along electrode 20 is controlled. When electrode 20 moves out of delivery catheter 12 and into tissue, insulator sleeve 28 can be positioned around electrode 20 as it moves its way through the tissue.

Alternatively, insulator sleeve 28 can be advanced along a desired length of electrode 20 after electrode 20 has been positioned around a targeted mass to be ablated. Insulator sleeve is thus capable of advancing through tissue along with electrode 20, or it can move through tissue without electrode 20 providing the source of movement. Thus, the desired ablation volume is defined by deployed electrodes 20, as well as the positioning of insulator sleeve 28 on each electrode. In this manner, a very precise ablation volume is created. Suitable materials that form insulator sleeve include but are not limited to nylon, polyimides, other thermoplastics, and the like.

FIG. 9 illustrates a percutaneous application of tissue ablation apparatus 10. Tissue ablation apparatus 10 can be used percutaneously to introduce electrodes 20 to the selected tissue mass or tumor. Electrodes 20 can remain in their non-deployed positions while being introduced percutaneously into the body, and delivered to a selected organ which contains the selected mass to be ablated. Delivery catheter 12 is removable from handle 18. When it is removed, electrode deployment device (the plurality of electrodes 20) can be inserted and removed from delivery catheter 12. An obturator 30 is inserted into delivery catheter 12 initially if a percutaneous procedure is to be performed. As shown in FIG. 10, obturator 30 can have a sharpened distal end 32 that pierces tissue and assists the introduction of delivery catheter 12 to a selected tissue site. The selected tissue site can be a body organ with a tumor or other mass, or the actual tumor itself.

Obturator 30 is then removed from delivery catheter 12 (FIG. 11). Electrode deployment device is then inserted into delivery catheter 12, and the catheter is then reattached to handle 18 (FIG. 12). As illustrated in FIG. 12, electrode deployment device can optionally include an electrode template 34 to guide the deployment of electrodes 20 to a surrounding relationship at an exterior of a selected mass in the tissue.

Electrodes 20 are then advanced out of distal end 16 of delivery catheter 12, and become deployed to form a desired ablative volume which surrounds the mass. In FIG. 13, delivery catheter 12 is positioned adjacent to the liver. Electrode deployment device is introduced into delivery catheter 12 with electrode template 34. Electrode deployment device now pierces the liver, and cam 22 advances electrodes 20 out of delivery catheter 12 into deployed positions. Each individual electrode 20 pierces the liver and travels through it until it is positioned in a surrounding relationship to the tumor. The ablative volume is selectable, and determined first by imaging the area to be ablated. The ablative volume is defined by the peripheries of all of the deployed electrodes 20 that surround the exterior of the tumor. Once the volume of ablation is determined, then an electrode set is selected which will become deployed to define the ablation volume. A variety of different factors are important in creating an ablation volume. Primarily, different electrodes 20 will have various degrees of deployment, based on type of electrode material, the level of pre-springing of the electrodes and the geometric configuration of the electrodes in their deployed states. Tissue ablation apparatus 10 permits different electrode 20 sets to be inserted into delivery catheter 12, in order to define a variety of ablation volumes.

Prior to ablation of the tumor, a pre-ablation step can be performed. A variety of different solutions, including electrolytic solutions such as saline, can be introduced to the tumor site, as shown in FIG. 14. FIG. 15 illustrates the application of RF energy to the tumor. Electrode insulator 28 is positioned on portions of electrodes 20 where there will be no ablation. This further defines the ablation volume. The actual electro-desiccation of the tumor, or other targeted masses or tissues, is shown in FIG. 16. Again, deployed electrodes 20, with their electrode insulators 28 positioned along sections of the electrodes, define the ablation volume, and the resulting amount of mass that is desiccated.

Optionally following desiccation, electrodes 20 can introduce a variety of solutions in a post-ablation process. This step is illustrated in FIG. 17. Suitable solutions include but are not limited to chemotherapeutic agents.

FIG. 8 illustrates tissue ablation apparatus 10 operated in a bipolar mode. Its monopolar operation is shown in FIG. 19. Each of the plurality of electrodes 20 can play different roles in the ablation process. There can be polarity shifting between the different electrodes.

A tissue ablation system 36, which can be modular, is shown in FIG. 20 and can include a display 38. Tissue ablation system 36 can also include an REF energy source, microwave source, ultrasound source, visualization devices such as cameras and VCR's, electrolytic and chemotherapeutic solution sources, and a controller which can be used to monitor temperature or impedance. One of the deployed electrodes 20 can be a microwave antenna coupled to a microwave source. This electrode can initially be coupled to RF power source 42 and is then switched to the microwave source

Referring now to FIG. 21, a power supply 40 delivers energy into RF power generator (source) 42 and then to electrodes 20 of tissue ablation apparatus 10. A multiplexer 46 measures current, voltage and temperature (at numerous temperature sensors which can be positioned on electrodes 20). Multiplexer 46 is driven by a controller 48, which can be a digital or analog controller, or a computer with software. When controller 48 is a computer, it can include a CPU coupled through a system bus. This system can include a keyboard, disk drive, or other non-volatile memory systems, a display, and other peripherals, as known in the art. Also coupled to the bus are a program memory and a data memory.

An operator interface 50 includes operator controls 52 and display 38. Controller 48 is coupled to imaging systems, including ultrasound transducers, temperature sensors, and viewing optics and optical fibers, if included.

Current and voltage are used to calculate impedance. Diagnostics are done through ultrasound, CT scanning, or other methods known in the art. Imaging can be performed before, during and after treatment.

Temperature sensors measure voltage and current that is delivered. The output of these sensors is used by controller 48 to control the delivery of RF power. Controller 48 can also control temperature and power. The amount of RF energy delivered controls the amount of power. A profile of power delivered can be incorporated in controller 38, as well as a pre-set amount of energy to be delivered can also be profiled.

Feedback can be the measurement of impedance or temperature, and occurs either at controller 48 or at electromagnetic energy source 42, e.g., RF or microwave, if it incorporates a controller. For impedance measurement, this can be achieved by supplying a small amount of non-ablation RF energy. Voltage and current are then measured.

Circuitry, software and feedback to controller 48 result in process control and are used to change, (i) power, including RF, ultrasound, and the like, (ii) the duty cycle (on-off and wattage), (iii) monopolar or bipolar energy delivery, (iv) chemotherapeutic and electrolytic solution delivery, flow rate and pressure and (v) determine when ablation is completed through time, temperature and/or impedance. These process variables can be controlled and varied based on temperature monitored at multiple sites, and impedance to current flow that is monitored, indicating changes in current carrying capability of the tissue during the ablative process.

The foregoing description of preferred embodiments of the present invention has been provided for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application, thereby enabling others skilled in the art to understand the invention for various embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the following claims and their equivalents.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US32057 *Apr 16, 1861 Joint of railboad-bails
US32066 *Apr 16, 1861 Apparatus for supplying steam-boilers with water
US34086 *Jan 7, 1862John WImprovement in boots or shoes
US3474777 *Feb 10, 1966Oct 28, 1969Amp IncMethod of administering therapeutic agents
US3834392 *Feb 1, 1973Sep 10, 1974Kli IncLaparoscopy system
US3858586 *Jun 1, 1973Jan 7, 1975Martin LessenSurgical method and electrode therefor
US3987795 *Aug 28, 1974Oct 26, 1976Valleylab, Inc.Electrosurgical devices having sesquipolar electrode structures incorporated therein
US3991770 *Dec 23, 1975Nov 16, 1976Leveen Harry HMethod for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation
US4011872 *Mar 28, 1975Mar 15, 1977Olympus Optical Co., Ltd.Electrical apparatus for treating affected part in a coeloma
US4016881 *May 27, 1975Apr 12, 1977Centre De Recherche Industrielle Du QuebecInstrument for use in laparoscopic tubal cauterization
US4016886 *Nov 26, 1974Apr 12, 1977The United States Of America As Represented By The United States Energy Research And Development AdministrationMethod for localizing heating in tumor tissue
US4026301 *Apr 21, 1975May 31, 1977Medtronic, Inc.Apparatus and method for optimum electrode placement in the treatment of disease syndromes such as spinal curvature
US4033351 *Sep 14, 1976Jul 5, 1977Siemens AktiengesellschaftBipolar cutting electrode for high-frequency surgery
US4043342 *Feb 26, 1976Aug 23, 1977Valleylab, Inc.Electrosurgical devices having sesquipolar electrode structures incorporated therein
US4074718 *Mar 17, 1976Feb 21, 1978Valleylab, Inc.Electrosurgical instrument
US4080959 *Jun 18, 1976Mar 28, 1978Leveen Robert FMethod for detection of tumors of the breast
US4085756 *Sep 30, 1976Apr 25, 1978Kenneth WeaverMethod and apparatus for performing an electrosurgical procedure
US4095602 *Sep 27, 1976Jun 20, 1978Leveen Harry HMulti-portal radiofrequency generator
US4119102 *Nov 11, 1976Oct 10, 1978Leveen Harry HRadio frequency treatment of tumors while inducing hypotension
US4121592 *Jul 20, 1976Oct 24, 1978Critical Systems, Inc.Apparatus for heating tissue
US4140130 *May 31, 1977Feb 20, 1979Storm Iii Frederick KElectrode structure for radio frequency localized heating of tumor bearing tissue
US4154246 *Jul 25, 1977May 15, 1979Leveen Harry HField intensification in radio frequency thermotherapy
US4230129 *Apr 22, 1976Oct 28, 1980Leveen Harry HRadio frequency, electromagnetic radiation device having orbital mount
US4237898 *Mar 27, 1978Dec 9, 1980Critical Systems, Inc.Apparatus for heating tissue and employing protection against transients
US4269174 *Aug 6, 1979May 26, 1981Medical Dynamics, Inc.Transcutaneous vasectomy apparatus and method
US4285346 *Mar 14, 1979Aug 25, 1981Harry V. LeVeenElectrode system
US4289135 *Nov 19, 1979Sep 15, 1981Tekniska Rontgencentralen AbApparatus for destroying a selected part of biological tissue
US4290435 *Sep 7, 1979Sep 22, 1981Thermatime A.G.Internally cooled electrode for hyperthermal treatment and method of use
US4303636 *May 12, 1978Dec 1, 1981Gordon Robert TCancer treatment
US4331654 *Jun 13, 1980May 25, 1982Eli Lilly And CompanyMagnetically-localizable, biodegradable lipid microspheres
US4337760 *Oct 31, 1979Jul 6, 1982Adolf SchwimmerMethod for the treatment of tumors with β-glucuronidase activity dependent pharmaceuticals
US4345588 *Jun 27, 1980Aug 24, 1982Northwestern UniversityMethod of delivering a therapeutic agent to a target capillary bed
US4346715 *May 13, 1980Aug 31, 1982The United States Of America As Represented By The Administrator Of The National Aeronautics And Space AdministrationHyperthermia heating apparatus
US4375220 *May 9, 1980Mar 1, 1983Matvias Fredrick MMicrowave applicator with cooling mechanism for intracavitary treatment of cancer
US4409993 *Jul 15, 1981Oct 18, 1983Olympus Optical Co., Ltd.Endoscope apparatus
US4411266 *Sep 24, 1980Oct 25, 1983Cosman Eric RThermocouple radio frequency lesion electrode
US4418692 *Nov 17, 1978Dec 6, 1983Guay Jean LouisDevice for treating living tissue with an electric current
US4461283 *Apr 2, 1982Jul 24, 1984Kabushiki Kaisha Medos KenkyushoEndoscopic laser coagulator
US4506680 *Mar 17, 1983Mar 26, 1985Medtronic, Inc.Drug dispensing body implantable lead
US4512762 *Nov 23, 1982Apr 23, 1985The Beth Israel Hospital AssociationMethod of treatment of atherosclerosis and a balloon catheter for same
US4524770 *Jan 25, 1983Jun 25, 1985Ahmad OrandiEndoscope injection needle
US4532924 *Apr 30, 1982Aug 6, 1985American Hospital Supply CorporationMultipolar electrosurgical device and method
US4545368 *Apr 13, 1983Oct 8, 1985Rand Robert WInduction heating method for use in causing necrosis of neoplasm
US4562838 *Jan 23, 1981Jan 7, 1986Walker William SElectrosurgery instrument
US4565200 *May 4, 1982Jan 21, 1986Cosman Eric RUniversal lesion and recording electrode system
US4574782 *Nov 21, 1983Mar 11, 1986Corning Glass WorksRadio frequency-induced hyperthermia for tumor therapy
US4583556 *Dec 13, 1982Apr 22, 1986M/A-Com, Inc.Microwave applicator/receiver apparatus
US4586490 *Feb 27, 1984May 6, 1986Katz Harry RNeedle inserting instrument means for interstitial radiotherapy
US4601296 *Oct 7, 1983Jul 22, 1986Yeda Research And Development Co., Ltd.Hyperthermia apparatus
US4648892 *Mar 22, 1985Mar 10, 1987Massachusetts Institute Of TechnologyMethod for making optical shield for a laser catheter
US4652257 *Mar 21, 1985Mar 24, 1987The United States Of America As Represented By The Secretary Of The NavyMagnetically-localizable, polymerized lipid vesicles and method of disrupting same
US4658819 *Sep 13, 1983Apr 21, 1987Valleylab, Inc.Electrosurgical generator
US4660571 *Jul 18, 1985Apr 28, 1987Cordis CorporationPercutaneous lead having radially adjustable electrode
US4662359 *Sep 23, 1983May 5, 1987Robert T. GordonUse of magnetic susceptibility probes in the treatment of cancer
US4676258 *Jun 5, 1986Jun 30, 1987Kureha Kagaku Kogyo Kabushiki KaishaDevice for hyperthermia
US4690130 *Dec 19, 1985Sep 1, 1987Mirell Stuart GElectromagnetic therapy control system
US4692139 *Sep 30, 1985Sep 8, 1987Stiles Frank BCatheter for effecting removal of obstructions from a biological duct
US4709701 *Apr 14, 1986Dec 1, 1987Medical Research & Development AssociatesApparatus for medical treatment by hyperthermia
US4753248 *Jun 24, 1987Jun 28, 1988Duke UniversityProbe translation system for use in hyperthermia treatment
US4763671 *Apr 25, 1986Aug 16, 1988Stanford UniversityMethod of treating tumors using selective application of heat and radiation
US4776086 *Sep 24, 1987Oct 11, 1988Kasevich Associates, Inc.Method and apparatus for hyperthermia treatment
US4800899 *Oct 29, 1986Jan 31, 1989Microthermia Technology, Inc.Apparatus for destroying cells in tumors and the like
US4813429 *May 5, 1987Mar 21, 1989Biodan Medical Systems Ltd.Catheter and probe
US4818542 *Mar 31, 1986Apr 4, 1989The University Of Kentucky Research FoundationPorous microspheres for drug delivery and methods for making same
US4823791 *May 8, 1987Apr 25, 1989Circon Acmi Division Of Circon CorporationElectrosurgical probe apparatus
US4823793 *Oct 30, 1985Apr 25, 1989The United States Of America As Represented By The Administrator Of The National Aeronuautics & Space AdministrationCutting head for ultrasonic lithotripsy
US4825880 *Jun 19, 1987May 2, 1989The Regents Of The University Of CaliforniaImplantable helical coil microwave antenna
US4838265 *Jan 21, 1988Jun 13, 1989Cosman Eric RLocalization device for probe placement under CT scanner imaging
US4846196 *Jan 27, 1987Jul 11, 1989Wiksell Hans O TMethod and device for the hyperthermic treatment of tumors
US4860744 *Nov 2, 1987Aug 29, 1989Raj K. AnandThermoelectrically controlled heat medical catheter
US4862887 *May 27, 1988Sep 5, 1989Gesellschaft Fuer Strahlen Und Umweltforschung (Gsf)Heart catheter
US4881543 *Jun 28, 1988Nov 21, 1989Massachusetts Institute Of TechnologyCombined microwave heating and surface cooling of the cornea
US4887614 *Apr 18, 1989Dec 19, 1989Kureha Kagaku Kogyo Kabushiki KaishaMedical electrode device
US4907589 *Apr 29, 1988Mar 13, 1990Cosman Eric RAutomatic over-temperature control apparatus for a therapeutic heating device
US4920978 *Aug 31, 1988May 1, 1990Triangle Research And Development CorporationMethod and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia
US4931047 *Sep 30, 1987Jun 5, 1990Cavitron, Inc.Method and apparatus for providing enhanced tissue fragmentation and/or hemostasis
US4940064 *Jun 30, 1987Jul 10, 1990Desai Jawahar MCatheter for mapping and ablation and method therefor
US4945912 *Nov 25, 1988Aug 7, 1990Sensor Electronics, Inc.Catheter with radiofrequency heating applicator
US4947842 *Feb 13, 1989Aug 14, 1990Medical Engineering And Development Institute, Inc.Method and apparatus for treating tissue with first and second modalities
US4950267 *Nov 18, 1988Aug 21, 1990Olympus Optical Co., Ltd.Laser beam treatment device for an endoscope
US4962761 *May 4, 1989Oct 16, 1990Golden Theodore AThermal bandage
US4963364 *Apr 10, 1989Oct 16, 1990Fox Sidney WMicroencapsulated antitumor agent
US4966604 *Jan 23, 1989Oct 30, 1990Interventional Technologies Inc.Expandable atherectomy cutter with flexibly bowed blades
US4976680 *Oct 7, 1988Dec 11, 1990Hayman Michael HApparatus for in situ radiotherapy
US4976711 *Apr 13, 1989Dec 11, 1990Everest Medical CorporationAblation catheter with selectively deployable electrodes
US4983159 *Sep 17, 1986Jan 8, 1991Rand Robert WInductive heating process for use in causing necrosis of neoplasms at selective frequencies
US4985022 *Nov 23, 1988Jan 15, 1991Med Institute, Inc.Catheter having durable and flexible segments
US4989601 *Sep 22, 1988Feb 5, 1991Medical Engineering & Development Institute, Inc.Method, apparatus, and substance for treating tissue having neoplastic cells
US5003991 *Mar 24, 1988Apr 2, 1991Olympus Optical Co., Ltd.Hyperthermia apparatus
US5007908 *Sep 29, 1989Apr 16, 1991Everest Medical CorporationElectrosurgical instrument having needle cutting electrode and spot-coag electrode
US5009656 *Aug 17, 1989Apr 23, 1991Mentor O&O Inc.Bipolar electrosurgical instrument
US5010897 *Apr 26, 1989Apr 30, 1991Leveen Harry HApparatus for deep heating of cancer
US5011483 *Jun 26, 1989Apr 30, 1991Dennis SleisterCombined electrosurgery and laser beam delivery device
US5013312 *Mar 19, 1990May 7, 1991Everest Medical CorporationBipolar scalpel for harvesting internal mammary artery
US5015227 *Apr 3, 1990May 14, 1991Valleylab Inc.Apparatus for providing enhanced tissue fragmentation and/or hemostasis
US5016615 *Feb 20, 1990May 21, 1991Riverside Research InstituteLocal application of medication with ultrasound
US5026959 *Oct 18, 1989Jun 25, 1991Tokyo Keiki Co. Ltd.Microwave radiator for warming therapy
US5047027 *Apr 20, 1990Sep 10, 1991Everest Medical CorporationTumor resector
US5055100 *Jun 19, 1989Oct 8, 1991Eugene OlsenSuction attachment for electrosurgical instruments or the like
US5057107 *Feb 19, 1991Oct 15, 1991Everest Medical CorporationAblation catheter with selectively deployable electrodes
US5059199Apr 4, 1990Oct 22, 1991Olympus Optical Co., Ltd.Treating device for endoscopes
US5067952Apr 2, 1990Nov 26, 1991Gudov Vasily FMethod and apparatus for treating malignant tumors by local hyperpyrexia
US5071419Apr 30, 1990Dec 10, 1991Everest Medical CorporationPercutaneous laparoscopic cholecystectomy instrument
US5078717Sep 10, 1990Jan 7, 1992Everest Medical CorporationAblation catheter with selectively deployable electrodes
US5080660May 11, 1990Jan 14, 1992Applied Urology, Inc.Electrosurgical electrode
US5083565Aug 3, 1990Jan 28, 1992Everest Medical CorporationElectrosurgical instrument for ablating endocardial tissue
US5084001Aug 9, 1990Jan 28, 1992Eric van't HooftMethod and apparatus for effecting radioactive therapy in an animal body
US5084045Sep 17, 1990Jan 28, 1992Helenowski Tomasz KSuction surgical instrument
US5085659Nov 21, 1990Feb 4, 1992Everest Medical CorporationBiopsy device with bipolar coagulation capability
US5099756Jun 1, 1989Mar 31, 1992Harry H. LeveenRadio frequency thermotherapy
US5100423Aug 21, 1990Mar 31, 1992Medical Engineering & Development Institute, Inc.Ablation catheter
US5115818Jan 10, 1991May 26, 1992Medtronic, Inc.Implantable electrode
US5119832Mar 15, 1990Jun 9, 1992Ravi XavierEpidural catheter with nerve stimulators
US5122137Apr 27, 1990Jun 16, 1992Boston Scientific CorporationTemperature controlled rf coagulation
US5125928Feb 19, 1991Jun 30, 1992Everest Medical CorporationAblation catheter with selectively deployable electrodes
US5128147Aug 6, 1990Jul 7, 1992Thermal Developments, Inc.Heat intensifier and localizer for radiofrequency thermotherapy
US5156151Feb 15, 1991Oct 20, 1992Cardiac Pathways CorporationEndocardial mapping and ablation system and catheter probe
US5167626Jan 27, 1992Dec 1, 1992Glaxo Inc.Medical capsule device actuated by radio-frequency (RF) signal
US5169396Jun 8, 1990Dec 8, 1992Kambiz DowlatshahiMethod for interstitial laser therapy
US5170789Oct 3, 1989Dec 15, 1992Perinchery NarayanInsertable NMR coil probe
US5170805Dec 11, 1990Dec 15, 1992Kensey Nash CorporationMethod of destroying tissue such as a gall bladder utilizing a sclerosing agent alone or with a symphysis agent
US5178620Feb 22, 1991Jan 12, 1993Advanced Angioplasty Products, Inc.Thermal dilatation catheter and method
US5183455Nov 5, 1990Feb 2, 1993Omnitron International, Inc.Apparatus for in situ radiotherapy
US5190517Jun 6, 1991Mar 2, 1993Valleylab Inc.Electrosurgical and ultrasonic surgical system
US5190539Jul 10, 1990Mar 2, 1993Texas A & M University SystemMicro-heat-pipe catheter
US5190541Oct 17, 1990Mar 2, 1993Boston Scientific CorporationSurgical instrument and method
US5190766Apr 12, 1991Mar 2, 1993Ken IshiharaMethod of controlling drug release by resonant sound wave
US5197466Jan 7, 1992Mar 30, 1993Med Institute Inc.Method and apparatus for volumetric interstitial conductive hyperthermia
US5197963Dec 2, 1991Mar 30, 1993Everest Medical CorporationElectrosurgical instrument with extendable sheath for irrigation and aspiration
US5197964Nov 12, 1991Mar 30, 1993Everest Medical CorporationBipolar instrument utilizing one stationary electrode and one movable electrode
US5203353Jan 3, 1992Apr 20, 1993Surgical Technologies, Inc.Method of penetrating and working in the vitreous humor of the eye
US5203782Mar 26, 1991Apr 20, 1993Gudov Vasily FMethod and apparatus for treating malignant tumors by local hyperpyrexia
US5205289Jun 8, 1990Apr 27, 1993Medical Instrumentation And Diagnostics CorporationThree-dimensional computer graphics simulation and computerized numerical optimization for dose delivery and treatment planning
US5207675Jul 15, 1991May 4, 1993Jerome CanadySurgical coagulation device
US5215103Sep 13, 1989Jun 1, 1993Desai Jawahar MCatheter for mapping and ablation and method therefor
US5217458Apr 9, 1992Jun 8, 1993Everest Medical CorporationBipolar biopsy device utilizing a rotatable, single-hinged moving element
US5222953Oct 2, 1991Jun 29, 1993Kambiz DowlatshahiApparatus for interstitial laser therapy having an improved temperature sensor for tissue being treated
US5236410Mar 11, 1991Aug 17, 1993Ferrotherm International, Inc.Tumor treatment method
US5236424Jun 5, 1992Aug 17, 1993Cardiac Pathways CorporationCatheter with retractable cannula for delivering a plurality of chemicals
US5246438Jan 9, 1992Sep 21, 1993Sensor Electronics, Inc.Method of radiofrequency ablation
US5249585Nov 5, 1990Oct 5, 1993Bsd Medical CorporationUrethral inserted applicator for prostate hyperthermia
US5251645Jun 26, 1991Oct 12, 1993Massachusetts Institute Of TechnologyAdaptive nulling hyperthermia array
US5252922Apr 30, 1991Oct 12, 1993Hewlett-Packard CompanyRadiofrequency focusing of magnetic resonance images
US5257451Nov 8, 1991Nov 2, 1993Ep Technologies, Inc.Method of making durable sleeve for enclosing a bendable electrode tip assembly
US5258006Aug 21, 1992Nov 2, 1993Everest Medical CorporationBipolar electrosurgical forceps
US5259394Dec 23, 1991Nov 9, 1993Ela MedicalEndocardiac lead having an active fastening means
US5259395Jan 15, 1992Nov 9, 1993Siemens Pacesetter, Inc.Pacemaker lead with extendable retractable lockable fixing helix
US5267994Feb 10, 1992Dec 7, 1993Conmed CorporationElectrosurgical probe
US5273535Nov 8, 1991Dec 28, 1993Ep Technologies, Inc.Catheter with electrode tip having asymmetric left and right curve configurations
US5275162Nov 25, 1992Jan 4, 1994Ep Technologies, Inc.Valve mapping catheter
US5277696Oct 13, 1992Jan 11, 1994Delma Elektro- Und Medizinische Apparatebau Gesellschaft MbhMedical high frequency coagulation instrument
US5281213Apr 16, 1992Jan 25, 1994Implemed, Inc.Catheter for ice mapping and ablation
US5281217Apr 13, 1992Jan 25, 1994Ep Technologies, Inc.Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5281218Jun 5, 1992Jan 25, 1994Cardiac Pathways CorporationCatheter having needle electrode for radiofrequency ablation
US5282797May 28, 1991Feb 1, 1994Cyrus ChessMethod for treating cutaneous vascular lesions
US5286253Oct 9, 1992Feb 15, 1994Linvatec CorporationAngled rotating surgical instrument
US5290286Dec 9, 1992Mar 1, 1994Everest Medical CorporationBipolar instrument utilizing one stationary electrode and one movable electrode
US5293869Sep 25, 1992Mar 15, 1994Ep Technologies, Inc.Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5295955Feb 14, 1992Mar 22, 1994Amt, Inc.Method and apparatus for microwave aided liposuction
US5300068Apr 21, 1992Apr 5, 1994St. Jude Medical, Inc.Electrosurgical apparatus
US5300069Aug 12, 1992Apr 5, 1994Daniel HunsbergerElectrosurgical apparatus for laparoscopic procedures and method of use
US5300099Mar 6, 1992Apr 5, 1994Urologix, Inc.Gamma matched, helical dipole microwave antenna
US5304214Jan 21, 1992Apr 19, 1994Med Institute, Inc.Transurethral ablation catheter
US5309910Sep 25, 1992May 10, 1994Ep Technologies, Inc.Cardiac mapping and ablation systems
US5313943Sep 25, 1992May 24, 1994Ep Technologies, Inc.Catheters and methods for performing cardiac diagnosis and treatment
US5314466Apr 13, 1992May 24, 1994Ep Technologies, Inc.Articulated unidirectional microwave antenna systems for cardiac ablation
US5322503Oct 18, 1991Jun 21, 1994Desai Ashvin HEndoscopic surgical instrument
US5328467Nov 8, 1991Jul 12, 1994Ep Technologies, Inc.Catheter having a torque transmitting sleeve
US5334193Nov 13, 1992Aug 2, 1994American Cardiac Ablation Co., Inc.Fluid cooled ablation catheter
US5334206Jun 5, 1992Aug 2, 1994Mitsubishi Denki Kabushiki KaishaLaser light irradiation apparatus
US5336222May 14, 1993Aug 9, 1994Boston Scientific CorporationIntegrated catheter for diverse in situ tissue therapy
US5342357Nov 13, 1992Aug 30, 1994American Cardiac Ablation Co., Inc.Fluid cooled electrosurgical cauterization system
US5348554Dec 1, 1992Sep 20, 1994Cardiac Pathways CorporationCatheter for RF ablation with cooled electrode
US5354296Mar 24, 1993Oct 11, 1994Symbiosis CorporationElectrocautery probe with variable morphology electrode
US5363861Nov 8, 1991Nov 15, 1994Ep Technologies, Inc.Electrode tip assembly with variable resistance to bending
US5365926Oct 13, 1992Nov 22, 1994Desai Jawahar MCatheter for mapping and ablation and method therefor
US5366490Dec 22, 1993Nov 22, 1994Vidamed, Inc.Medical probe device and method
US5368592Sep 23, 1993Nov 29, 1994Ep Technologies, Inc.Articulated systems for cardiac ablation
US5370675Feb 2, 1993Dec 6, 1994Vidamed, Inc.Medical probe device and method
US5370678Dec 7, 1993Dec 6, 1994Ep Technologies, Inc.Steerable microwave antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5383876Mar 22, 1994Jan 24, 1995American Cardiac Ablation Co., Inc.Fluid cooled electrosurgical probe for cutting and cauterizing tissue
US5383917Jul 5, 1991Jan 24, 1995Jawahar M. DesaiDevice and method for multi-phase radio-frequency ablation
US5385544May 14, 1993Jan 31, 1995Vidamed, Inc.BPH ablation method and apparatus
US5397339May 7, 1993Mar 14, 1995Desai; Jawahar M.Catheter for mapping and ablation and method therefor
US5398683Jul 16, 1993Mar 21, 1995Ep Technologies, Inc.Combination monophasic action potential/ablation catheter and high-performance filter system
US5401272Feb 16, 1994Mar 28, 1995Envision Surgical Systems, Inc.Multimodality probe with extendable bipolar electrodes
US5403311Mar 29, 1993Apr 4, 1995Boston Scientific CorporationElectro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5405346Dec 3, 1993Apr 11, 1995Fidus Medical Technology CorporationTunable microwave ablation catheter
US5409453Aug 19, 1993Apr 25, 1995Vidamed, Inc.Steerable medical probe with stylets
US5411025Jun 30, 1992May 2, 1995Cordis Webster, Inc.Cardiovascular catheter with laterally stable basket-shaped electrode array
US5417687Apr 30, 1993May 23, 1995Medical Scientific, Inc.Bipolar electrosurgical trocar
US5421819May 13, 1993Jun 6, 1995Vidamed, Inc.Medical probe device
US5423807Jan 24, 1994Jun 13, 1995Implemed, Inc.Cryogenic mapping and ablation catheter
US5423808Nov 29, 1993Jun 13, 1995Ep Technologies, Inc.Systems and methods for radiofrequency ablation with phase sensitive power detection
US5423811Mar 16, 1994Jun 13, 1995Cardiac Pathways CorporationMethod for RF ablation using cooled electrode
US5433708Jun 7, 1993Jul 18, 1995Innerdyne, Inc.Method and device for thermal ablation having improved heat transfer
US5435805May 13, 1993Jul 25, 1995Vidamed, Inc.Medical probe device with optical viewing capability
US5437662Feb 17, 1994Aug 1, 1995American Cardiac Ablation Co., Inc.Fluid cooled electrosurgical cauterization system
US5437664Jan 18, 1994Aug 1, 1995Endovascular, Inc.Apparatus and method for venous ligation
US5456662May 9, 1994Oct 10, 1995Edwards; Stuart D.Method for reducing snoring by RF ablation of the uvula
US5456682Feb 2, 1994Oct 10, 1995Ep Technologies, Inc.Electrode and associated systems using thermally insulated temperature sensing elements
US5458596May 6, 1994Oct 17, 1995Dorsal Orthopedic CorporationMethod and apparatus for controlled contraction of soft tissue
US5458597Nov 8, 1993Oct 17, 1995Zomed InternationalDevice for treating cancer and non-malignant tumors and methods
US5462521Dec 21, 1993Oct 31, 1995Angeion CorporationFluid cooled and perfused tip for a catheter
US5470308Nov 19, 1993Nov 28, 1995Vidamed, Inc.Medical probe with biopsy stylet
US5470309Jan 12, 1994Nov 28, 1995Vidamed, Inc.Medical ablation apparatus utilizing a heated stylet
US5471982Sep 29, 1992Dec 5, 1995Ep Technologies, Inc.Cardiac mapping and ablation systems
US5472441Mar 11, 1994Dec 5, 1995Zomed InternationalDevice for treating cancer and non-malignant tumors and methods
US5484400Mar 23, 1994Jan 16, 1996Vidamed, Inc.Dual channel RF delivery system
US5486161Nov 8, 1993Jan 23, 1996Zomed InternationalMedical probe device and method
US5500012Jul 8, 1994Mar 19, 1996Angeion CorporationAblation catheter system
US5505730Jun 24, 1994Apr 9, 1996Stuart D. EdwardsThin layer ablation apparatus
US5507743Aug 16, 1994Apr 16, 1996Zomed InternationalCoiled RF electrode treatment apparatus
US5509419Dec 16, 1993Apr 23, 1996Ep Technologies, Inc.Cardiac mapping and ablation systems
US5514130Oct 11, 1994May 7, 1996Dorsal Med InternationalRF apparatus for controlled depth ablation of soft tissue
US5514131Sep 23, 1994May 7, 1996Stuart D. EdwardsMethod for the ablation treatment of the uvula
US5520684Aug 3, 1994May 28, 1996Imran; Mir A.Transurethral radio frequency apparatus for ablation of the prostate gland and method
US5531676Sep 27, 1994Jul 2, 1996Vidamed, Inc.Medical probe device and method
US5531677Apr 11, 1995Jul 2, 1996Vidamed, Inc.Steerable medical probe with stylets
US5536240Sep 27, 1994Jul 16, 1996Vidamed, Inc.Medical probe device and method
US5536267Aug 12, 1994Jul 16, 1996Zomed InternationalMultiple electrode ablation apparatus
US5540655Jan 5, 1995Jul 30, 1996Vidamed, Inc.PBH ablation method and apparatus
US5542915Jan 12, 1994Aug 6, 1996Vidamed, Inc.Thermal mapping catheter with ultrasound probe
US5542916Sep 28, 1994Aug 6, 1996Vidamed, Inc.Dual-channel RF power delivery system
US5542928Jun 27, 1994Aug 6, 1996Innerdyne, Inc.Method and device for thermal ablation having improved heat transfer
US5545161Oct 7, 1994Aug 13, 1996Cardiac Pathways CorporationCatheter for RF ablation having cooled electrode with electrically insulated sleeve
US5545171Sep 22, 1994Aug 13, 1996Vidamed, Inc.Anastomosis catheter
US5545193Aug 22, 1995Aug 13, 1996Ep Technologies, Inc.Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5546267Dec 8, 1994Aug 13, 1996Illinois Tool Works Inc.Communication circuit protector
US5548597Oct 13, 1994Aug 20, 1996Hitachi, Ltd.Failure diagnosis apparatus and a method thereof
US5549108Jun 1, 1994Aug 27, 1996Ep Technologies, Inc.Cardiac mapping and ablation systems
US5549644Feb 2, 1994Aug 27, 1996Vidamed, Inc.Transurethral needle ablation device with cystoscope and method for treatment of the prostate
US5551426Jul 14, 1993Sep 3, 1996Hummel; John D.Intracardiac ablation and mapping catheter
US5554110Jan 12, 1994Sep 10, 1996Vidamed, Inc.Medical ablation apparatus
US5556377Dec 22, 1993Sep 17, 1996Vidamed, Inc.Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5558672Aug 4, 1994Sep 24, 1996Vidacare, Inc.Thin layer ablation apparatus
US5558673Sep 30, 1994Sep 24, 1996Vidamed, Inc.Medical probe device and method having a flexible resilient tape stylet
US5560358Sep 8, 1994Oct 1, 1996Radionics, Inc.Connector design for multi-contact medical electrode
US5562703Jun 14, 1994Oct 8, 1996Desai; Ashvin H.Endoscopic surgical instrument
US5599345Aug 24, 1994Feb 4, 1997Zomed International, Inc.RF treatment apparatus
US5599346Aug 24, 1994Feb 4, 1997Zomed International, Inc.RF treatment system
US5609151Sep 8, 1994Mar 11, 1997Medtronic, Inc.Method for R-F ablation
US5620481Jun 7, 1995Apr 15, 1997Desai; Jawahar M.Device for multi-phase radio-frequency ablation
US5709224Jun 7, 1995Jan 20, 1998Radiotherapeutics CorporationMethod and device for permanent vessel occlusion
USRE32057Jun 30, 1982Dec 31, 1985 Radio frequency treatment of tumors while inducing hypotension
USRE32066Jun 30, 1982Jan 21, 1986 Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation
USRE34086Aug 10, 1990Oct 6, 1992 Medical placement device
DE1007960BSep 19, 1953May 9, 1957Richard WolfKoagulationselektrode fuer Endoskope
DE2124684A1May 18, 1971Nov 30, 1972Stadelmann WTitle not available
DE3838840C2Nov 17, 1988Feb 20, 1997Leibinger GmbhHochfrequenzkoagulationsvorrichtung für chirurgische Zwecke
DE3930451C2Sep 12, 1989Sep 26, 2002Leibinger GmbhVorrichtung für die Hochfrequenzkoagulation von biologischem Gewebe
EP0370890B1Nov 21, 1989Nov 8, 1995Technomed Medical SystemsApparatus for the surgical treatment of tissues by hyperthermia, preferably the prostate, equipped with heat protection means preferably comprising means forming radioreflecting screen
EP0462302A1Jun 19, 1990Dec 27, 1991Bsd Medical CorporationUrethral inserted applicator for prostate hyperthermia
EP0502268A1Mar 4, 1991Sep 9, 1992Everest Medical CorporationElectrosurgical instrument having needle cutting electrode and spot-coagulation electrode
EP0519415A1Jun 17, 1992Dec 23, 1992SMA SEGNALAMENTO MARITTIMO ED AEREO S.p.A.Microwave apparatus for clinical hyperthermia in endogenous thermotherapy
EP0608609B1Nov 30, 1993Sep 26, 2001Cardiac Pathways CorporationCatheter for RF ablation with cooled electrode
FR2283701B3 Title not available
FR2670664A1 Title not available
JP2121675A Title not available
JP63275632A Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6221071 *Jun 4, 1999Apr 24, 2001Scimed Life Systems, Inc.Rapid electrode deployment
US6517498 *Jul 20, 2000Feb 11, 2003Senorx, Inc.Apparatus and method for tissue capture
US6572614 *Jan 2, 2001Jun 3, 2003Alan G. EllmanBipolar arthroscopic probe
US6634363Mar 27, 2000Oct 21, 2003Broncus Technologies, Inc.Methods of treating lungs having reversible obstructive pulmonary disease
US6638277Jul 2, 2001Oct 28, 2003Scimed Life Systems, Inc.Tumor ablation needle with independently activated and independently traversing tines
US6673063 *Apr 10, 2001Jan 6, 2004Expanding Concepts, Llc.Epidural thermal posterior annuloplasty
US6702810Mar 1, 2001Mar 9, 2004Tissuelink Medical Inc.Fluid delivery system and controller for electrosurgical devices
US6706039May 25, 2001Mar 16, 2004Medtronic, Inc.Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6780177Aug 27, 2002Aug 24, 2004Board Of Trustees Of The University Of ArkansasConductive interstitial thermal therapy device
US6872203Jan 6, 2003Mar 29, 2005Board Of Trustees Of The University Of ArkansasConductive interstitial thermal therapy device
US6932814Jun 28, 2001Aug 23, 2005The United States Of America As Represented By The Department Of Health And Human ServicesRadiofrequency probes for tissue treatment and methods of use
US6961602Dec 31, 2001Nov 1, 2005Biosense Webster, Inc.Catheter having multiple spines each having electrical mapping and location sensing capabilities
US6962589Jan 8, 2004Nov 8, 2005Medtronic, Inc.Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US7003342Jun 2, 2003Feb 21, 2006Biosense Webster, Inc.Catheter and method for mapping a pulmonary vein
US7004938Nov 27, 2002Feb 28, 2006Medwaves, Inc.Radio-frequency-based catheter system with improved deflection and steering mechanisms
US7025767Sep 16, 2003Apr 11, 2006Boston Scientific Scimed, Inc.Tumor ablation needle with independently activated and independently traversing tines
US7027851Sep 25, 2003Apr 11, 2006Biosense Webster, Inc.Multi-tip steerable catheter
US7070595Aug 8, 2003Jul 4, 2006Medwaves, Inc.Radio-frequency based catheter system and method for ablating biological tissues
US7081113Jun 26, 2003Jul 25, 2006Depuy Acromed, Inc.Helical probe
US7087053May 27, 2004Aug 8, 2006St. Jude Medical, Atrial Fibrillation Division, Inc.Catheter with bifurcated, collapsible tip for sensing and ablating
US7089045Aug 30, 2002Aug 8, 2006Biosense Webster, Inc.Catheter and method for mapping Purkinje fibers
US7099712Feb 16, 2005Aug 29, 2006Biosense Webster, Inc.Catheter having multiple spines each having electrical mapping and location sensing capabilities
US7195629Aug 18, 2003Mar 27, 2007Boston Scientific Scimed, Inc.Methods and systems for focused bipolar tissue ablation
US7228164Dec 29, 2004Jun 5, 2007Biosense Webster Inc.Catheter and method for mapping Purkinje fibers
US7257435Feb 21, 2006Aug 14, 2007Biosense Webster, Inc.Catheter and method for mapping a pulmonary vein
US7261711Nov 8, 2005Aug 28, 2007Medtronic, Inc.Electrosurgical instrument
US7282051Feb 4, 2004Oct 16, 2007Boston Scientific Scimed, Inc.Ablation probe for delivering fluid through porous structure
US7302285Dec 30, 2005Nov 27, 2007Biosense Webster, Inc.Catheter and method for mapping purkinje fibers
US7361173Jan 3, 2005Apr 22, 2008Board Of Trustees Of The University Of ArkansasConductive interstitial thermal therapy device
US7363071 *Mar 11, 2003Apr 22, 2008Endocare, Inc.Computer guided ablation of tissue using integrated ablative/temperature sensing devices
US7399299Jul 12, 2004Jul 15, 2008S.D.M.H. Pty. Ltd.Thermal ablation of biological tissue
US7412274Dec 30, 2005Aug 12, 2008Biosense Webster, Inc.Multi-tip steerable catheter
US7416549Oct 10, 2003Aug 26, 2008Boston Scientific Scimed, Inc.Multi-zone bipolar ablation probe assembly
US7416550 *Jan 22, 2004Aug 26, 2008The Regents Of The University Of CaliforniaMethod and apparatus for the control and monitoring of shape change in tissue
US7645277Dec 22, 2005Jan 12, 2010Salient Surgical Technologies, Inc.Fluid-assisted medical device
US7651494Jan 29, 2003Jan 26, 2010Salient Surgical Technologies, Inc.Fluid-assisted medical device
US7678106Jan 10, 2005Mar 16, 2010Halt Medical, Inc.Gynecological ablation procedure and system
US7680543Sep 14, 2007Mar 16, 2010Lazure Technologies, LlcTissue ablation and removal
US7722606Sep 14, 2007May 25, 2010LaZúre Technologies, LLCDevice and method for destruction of cancer cells
US7727232Feb 4, 2005Jun 1, 2010Salient Surgical Technologies, Inc.Fluid-assisted medical devices and methods
US7738938Aug 13, 2007Jun 15, 2010Biosense Webster, Inc.Catheter and method for mapping a pulmonary vein
US7740017Apr 29, 2005Jun 22, 2010Asthmatx, Inc.Method for treating an asthma attack
US7770584Aug 10, 2010Asthmatx, Inc.Modification of airways by application of microwave energy
US7811282Nov 14, 2005Oct 12, 2010Salient Surgical Technologies, Inc.Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof
US7815634Dec 22, 2003Oct 19, 2010Salient Surgical Technologies, Inc.Fluid delivery system and controller for electrosurgical devices
US7815637Feb 22, 2006Oct 19, 2010Ormsby Theodore CRadio-frequency-based catheter system with improved deflection and steering mechanisms
US7818048Jun 2, 2003Oct 19, 2010Biosense Webster, Inc.Catheter and method for mapping a pulmonary vein
US7837679Jul 17, 2006Nov 23, 2010Asthmatx, Inc.Control system and process for application of energy to airway walls and other mediums
US7853331May 25, 2006Dec 14, 2010Asthmatx, Inc.Medical device with procedure improvement features
US7854734Jul 17, 2006Dec 21, 2010Asthmatx, Inc.Control system and process for application of energy to airway walls and other mediums
US7921855Dec 11, 2006Apr 12, 2011Asthmatx, Inc.Method for treating an asthma attack
US7931647Oct 20, 2006Apr 26, 2011Asthmatx, Inc.Method of delivering energy to a lung airway using markers
US7938123Dec 1, 2008May 10, 2011Asthmatx, Inc.Modification of airways by application of cryo energy
US7949407Dec 29, 2006May 24, 2011Asthmatx, Inc.Energy delivery devices and methods
US7951148Feb 6, 2004May 31, 2011Salient Surgical Technologies, Inc.Electrosurgical device having a tissue reduction sensor
US7959629Jul 15, 2008Jun 14, 2011Boston Scientific Scimed, Inc.Multi-zone bipolar ablation probe assembly
US7979107Aug 6, 2009Jul 12, 2011Vanderbilt UniversitySystem and method for differentiation of normal and malignant in vivo liver tissues
US7993335Oct 17, 2006Aug 9, 2011Bovie Medical CorporationAblation probe for delivering fluid through porous structure
US8043289May 27, 2008Oct 25, 2011Boston Scientific Scimed, Inc.Methods and systems for focused bipolar tissue ablation
US8048069Apr 13, 2007Nov 1, 2011Medtronic, Inc.User interface for ablation therapy
US8073551Apr 4, 2007Dec 6, 2011University Health NetworkCoil electrode apparatus for thermal therapy
US8109926 *Sep 14, 2007Feb 7, 2012Lazure Scientific, Inc.Ablation probe with deployable electrodes
US8152799Sep 8, 2010Apr 10, 2012Medwaves, Inc.Radio frequency-based catheter system with improved deflection and steering mechanisms
US8161978Apr 24, 2012Asthmatx, Inc.Methods for treating asthma by damaging nerve tissue
US8162939 *Mar 7, 2006Apr 24, 2012Olympus Medical Systems Corp.Medical treatment device
US8216224 *Aug 17, 2007Jul 10, 2012Angiodynamics, IncTissue surface treatment apparatus and method
US8216226 *Apr 7, 2008Jul 10, 2012Boston Scientific Scimed, Inc.Radiofrequency ablation device
US8216231Sep 21, 2011Jul 10, 2012Boston Scientific Scimed, Inc.Methods and systems for focused bipolar tissue ablation
US8216235Nov 21, 2007Jul 10, 2012Boston Scientific Scimed, Inc.Liquid infusion apparatus for radiofrequency tissue ablation
US8257413Sep 22, 2006Sep 4, 2012Asthmatx, Inc.Modification of airways by application of energy
US8267094Sep 18, 2012Asthmatx, Inc.Modification of airways by application of ultrasound energy
US8308722Jul 23, 2007Nov 13, 2012Medwaves, Inc.Hollow conductive coaxial cable for radio frequency based tissue ablation system
US8348940Jun 29, 2012Jan 8, 2013Boston Scientific Scimed, Inc.Methods and systems for focused bipolar tissue ablation
US8353906 *Mar 20, 2008Jan 15, 2013Ceramatec, Inc.Electrochemical probe and method for in situ treatment of a tissue
US8465486Jun 18, 2013Asthmatx, Inc.Modification of airways by application of energy
US8469954Jun 29, 2012Jun 25, 2013Boston Scientific Scimed, Inc.Radiofrequency ablation device
US8486065Jun 10, 2002Jul 16, 2013Wisconsin Alumni Research FoundationRadio-frequency ablation system and method using multiple electrodes
US8535306Nov 5, 2007Sep 17, 2013Angiodynamics, Inc.Ablation devices and methods of using the same
US8562602Sep 15, 2008Oct 22, 2013Lazure Technologies, LlcMulti-layer electrode ablation probe and related methods
US8591472Jul 22, 2011Nov 26, 2013Ceramatec, Inc.Apparatus for administering a therapeutic agent into tissue using a needle as the material treatment module
US8640711Dec 9, 2010Feb 4, 2014Asthmatx, Inc.Method for treating an asthma attack
US8728139Apr 16, 2010May 20, 2014Lazure Technologies, LlcSystem and method for energy delivery to a tissue using an electrode array
US8740895Jun 28, 2013Jun 3, 2014Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US8744599Mar 10, 2008Jun 3, 2014St. Jude Medical, Atrial Fibrillation Division, Inc.High density mapping catheter
US8758337Sep 1, 2011Jun 24, 2014Medtronic, Inc.User interface for ablation therapy
US8777889Aug 1, 2005Jul 15, 2014Ceramatec, Inc.Apparatus and method for administering a therapeutic agent into tissue
US8777943Jun 28, 2013Jul 15, 2014Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US8808282 *Mar 5, 2007Aug 19, 2014Covidien LpMicrowave antenna having a curved configuration
US8814856Apr 30, 2007Aug 26, 2014Medtronic, Inc.Extension and retraction mechanism for a hand-held device
US8845635Jan 18, 2006Sep 30, 2014S.D.M.H. Pty. Ltd.Device and method for thermal ablation of biological tissue using spherical ablation patterns
US8858545Aug 16, 2010Oct 14, 2014Board Of Trustees Of The University Of ArkansasSelective conductive interstitial thermal therapy device
US8911439Nov 11, 2010Dec 16, 2014Holaira, Inc.Non-invasive and minimally invasive denervation methods and systems for performing the same
US8915911Apr 13, 2010Dec 23, 2014Lazure Technologies, LlcDevice and method for destruction of cancer cells
US8932289Sep 26, 2011Jan 13, 2015Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US8944071Aug 20, 2012Feb 3, 2015Asthmatx, Inc.Method for treating an asthma attack
US8945114Apr 26, 2007Feb 3, 2015Medtronic, Inc.Fluid sensor for ablation therapy
US8986520Mar 11, 2013Mar 24, 2015Ceramatec, Inc.Apparatus administering a therapeutic agent into tissue
US9005195Sep 26, 2011Apr 14, 2015Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US9017324Jun 28, 2013Apr 28, 2015Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US9027564May 10, 2013May 12, 2015Asthmatx, Inc.Method for treating a lung
US9033976May 16, 2013May 19, 2015Asthmatx, Inc.Modification of airways by application of energy
US9039698Nov 24, 2010May 26, 2015Medwaves, Inc.Radio frequency ablation system with tracking sensor
US9095325May 22, 2006Aug 4, 2015Senorx, Inc.Tissue cutting member for a biopsy device
US20040077951 *Jul 3, 2003Apr 22, 2004Wei-Chiang LinApparatus and methods of detection of radiation injury using optical spectroscopy
US20040087848 *Sep 25, 2003May 6, 2004Mejia Ruth N.Multi-tip steerable catheter
US20040106917 *Aug 8, 2003Jun 3, 2004Ormsby Theodore C.Radio-frequency based catheter system and method for ablating biological tissues
US20040111084 *Nov 24, 2003Jun 10, 2004Expanding Concepts, L.L.C.Epidural thermal posterior annuloplasty
US20040143181 *Mar 11, 2003Jul 22, 2004Damasco Sanford D.Computer guided ablation of tissue using integrated ablative/temperature sensing devices
US20040143259 *Jan 8, 2004Jul 22, 2004Medtronic, Inc.Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US20040230187 *Mar 9, 2004Nov 18, 2004Lee Fred T.Multipolar electrode system for volumetric radiofrequency ablation
US20040236320 *Jan 22, 2004Nov 25, 2004Protsenko Dmitry EMethod and apparatus for the control and monitoring of shape change in tissue
US20040242984 *Jun 2, 2003Dec 2, 2004Plaza Claudio P.Catheter and method for mapping a pulmonary vein
US20040267251 *Jun 26, 2003Dec 30, 2004Jeffrey SuttonHelical probe
US20050049586 *Jul 12, 2004Mar 3, 2005Daniel Steven A.Thermal ablation of biological tissue
US20050080409 *Oct 10, 2003Apr 14, 2005Scimed Life Systems, Inc.Multi-zone bipolar ablation probe assembly
US20050080410 *Oct 14, 2003Apr 14, 2005Scimed Life Systems, Inc.Liquid infusion apparatus for radiofrequency tissue ablation
US20050113660 *Dec 29, 2004May 26, 2005Biosense Webster, Inc.Catheter and method for mapping purkinje fibers
US20050119645 *Jan 3, 2005Jun 2, 2005Gal ShafirsteinConductive interstitial thermal therapy device
US20050148837 *Feb 16, 2005Jul 7, 2005Fuimaono Kristine B.Catheter having multiple spines each having electrical mapping and location sensing capabilities
US20050149013 *Jan 10, 2005Jul 7, 2005Lee Bruce B.Gynecological ablation procedure and system
US20050187489 *Apr 4, 2005Aug 25, 2005Wardle John L.Electrosurgical specimen-collection system
US20050190982 *Nov 24, 2004Sep 1, 2005Matsushita Electric Industrial Co., Ltd.Image reducing device and image reducing method
US20050245923 *Apr 29, 2004Nov 3, 2005Medtronic, Inc.Biopolar virtual electrode for transurethral needle ablation
US20050267463 *May 27, 2004Dec 1, 2005Vanney Guy PCatheter with bifurcated, collapsible tip for sensing and ablating
US20080167650 *Mar 20, 2008Jul 10, 2008Joshi Ashok VElectrochemical Probe and Method for In Situ Treatment of a Tissue
US20080255553 *Apr 7, 2008Oct 16, 2008Boston Scientific Scimed, Inc.Radiofrequency ablation device
US20090306656 *Dec 10, 2009Kai DesingerTherapy apparatus for thermal sclerosing of body tissue
EP1870051A1 *Mar 7, 2006Dec 26, 2007Olympus Medical Systems Corp.Medical treatment device
EP2305159A3 *Mar 27, 2003Apr 13, 2011Vivant Medical, Inc.Microwave antenna having a curved configuration
WO2002022032A1Sep 14, 2001Mar 21, 2002Radiotherapeutics CorpMethods and systems for focused bipolar tissue ablation
WO2002038066A1 *Jun 1, 2001May 16, 2002Lee Hee YoungBleeding point searching and operating device of comprising air brush
WO2003047448A1 *Nov 27, 2002Jun 12, 2003Medwaves IncRadio-frequency-based catheter system with improved deflection and steering mechanisms
WO2004016155A2 *Aug 14, 2003Feb 26, 2004Beth Israel HospitalApparatus for multifocal deposition and analysis and methods for its use
Legal Events
DateCodeEventDescription
Aug 7, 1997ASAssignment
Owner name: VENTURE BANKING GROUP, CALIFORNIA
Free format text: SECURITY INTEREST;ASSIGNOR:RITA MEDICAL SYSTEMS, INC.;REEL/FRAME:008628/0643
Effective date: 19970721
Aug 18, 1997ASAssignment
Owner name: RITA MEDICAL SYSTEMS, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:EDWARDS, STUART D.;LAX, RONALD G.;SHARKEY, HUGH;REEL/FRAME:008714/0638;SIGNING DATES FROM 19970808 TO 19970811
Jul 27, 1999ASAssignment
Owner name: TRANSAMERICA BUSINESS CREDIT CORPORATION, ILLINOIS
Free format text: SECURITY AGREEMENT;ASSIGNOR:RITA MEDICAL SYSTEMS, INC.;REEL/FRAME:010113/0594
Effective date: 19990629
Dec 8, 2003FPAYFee payment
Year of fee payment: 4
Feb 16, 2007ASAssignment
Owner name: RITA MEDICAL SYSTEMS, INC., CALIFORNIA
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:VENTURE BANKING GROUP, A/K/A VENTURE LENDING, A DIVISION OF CUPERTINO NATIONAL BANK;REEL/FRAME:018898/0325
Effective date: 20070209
Nov 9, 2007FPAYFee payment
Year of fee payment: 8
Mar 8, 2010ASAssignment
Owner name: ANGIODYNAMICS, INC,NEW YORK
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RITA MEDICAL SYSTEMS, LLC;REEL/FRAME:024035/0632
Effective date: 20081017
Free format text: MERGER;ASSIGNOR:RITA MEDICAL SYSTEMS, INC;REEL/FRAME:024035/0626
Owner name: RITA MEDICAL SYSTEMS, LLC,CALIFORNIA
Effective date: 20070129
Sep 19, 2011FPAYFee payment
Year of fee payment: 12
May 23, 2012ASAssignment
Effective date: 20120522
Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Free format text: SECURITY AGREEMENT;ASSIGNOR:ANGIODYNAMICS, INC.;REEL/FRAME:028260/0329
Aug 16, 2012ASAssignment
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:TRANSAMERICA BUSINESS CREDIT CORPORATION;REEL/FRAME:028801/0326
Owner name: RITA MEDICAL SYSTEMS, INC., CALIFORNIA
Effective date: 20120816
Sep 30, 2013ASAssignment
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:031315/0361
Owner name: ANGIODYNAMICS, INC., NEW YORK
Effective date: 20130919
Free format text: SECURITY AGREEMENT;ASSIGNOR:ANGIODYNAMICS, INC.;REEL/FRAME:031315/0720
Effective date: 20130919
Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT